Cargando…

Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study

Neuroblastoma is the most common extracranial solid malignancy in children. This study was undertaken to determine the long-term survival of neuroblastoma patients receiving conventional therapeutics (surgery, chemotherapy, and radiotherapy). The neuroblastoma patients examined were registered in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qilan, Wang, Jianqun, Cheng, Yang, Hu, Anpei, Li, Dan, Wang, Xiaojing, Guo, Yanhua, Zhou, Yi, Chen, Guo, Bao, Banghe, Gao, Haiyang, Song, Jiyu, Du, Xinyi, Zheng, Liduan, Tong, Qiangsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918249/ https://www.ncbi.nlm.nih.gov/pubmed/36769402 http://dx.doi.org/10.3390/jcm12030754

Ejemplares similares

Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity
por: Hu, Anpei, et al.
Publicado: (2023)

p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation
por: Yang, Feng, et al.
Publicado: (2021)

circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression
por: Li, Hongjun, et al.
Publicado: (2023)

Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression
por: Wang, Jianqun, et al.
Publicado: (2021)

Therapeutic Targeting of MZF1‐AS1/PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression
por: Fang, Erhu, et al.
Publicado: (2019)

RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
por: Song, Huajie, et al.
Publicado: (2020)

Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
por: Song, Huajie, et al.
Publicado: (2023)

Therapeutic targeting of circ‐CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression
por: Li, Huanhuan, et al.
Publicado: (2019)

Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
por: Fang, Erhu, et al.
Publicado: (2020)

Robot-Assisted versus Trans-Umbilical Multiport Laparoscopic Ureteral Reimplantation for Pediatric Benign Distal Ureteral Stricture: Mid-Term Results at a Single Center
por: Guo, Yanhua, et al.
Publicado: (2022)

Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
por: Yang, Feng, et al.
Publicado: (2019)

Correction: Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
por: Yang, Feng, et al.
Publicado: (2023)

Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase
por: Qu, Hongxia, et al.
Publicado: (2016)

Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4
por: Li, Dan, et al.
Publicado: (2018)

microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5′-untranslated region in neuroblastoma
por: Qu, Hongxia, et al.
Publicado: (2016)

A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma
por: Zeng, Hao, et al.
Publicado: (2023)

FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
por: Li, Dan, et al.
Publicado: (2013)

Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2
por: Li, Dan, et al.
Publicado: (2015)

miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14
por: Xiang, Xuan, et al.
Publicado: (2015)

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly
por: Wang, Peng, et al.
Publicado: (2016)

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis
por: Wang, Wenyi, et al.
Publicado: (2023)

Effect of EGFR-TKIs combined with craniocerebral radiotherapy on the prognosis of EGFR-mutant lung adenocarcinoma patients with brain metastasis: A propensity-score matched analysis
por: Deng, Guangchuan, et al.
Publicado: (2023)

All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis
por: Chen, Ru, et al.
Publicado: (2023)

VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-κB signaling pathway
por: Tong, Qiangsong, et al.
Publicado: (2006)

Association Between Partial Pressure of Carbon Dioxide and Immediate Seizures in Patients With Primary Intracerebral Hemorrhage: A Propensity-Matched Analysis
por: Pan, Zhiming, et al.
Publicado: (2022)

Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis
por: Du, Kaixin, et al.
Publicado: (2019)

Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis
por: Zeng, Qi, et al.
Publicado: (2016)

Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis
por: Zhang, Fan, et al.
Publicado: (2015)

Effective Learning During COVID-19: Multilevel Covariates Matching and Propensity Score Matching
por: Guo, Siying, et al.
Publicado: (2022)

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
por: Liu, Chieh-Min, et al.
Publicado: (2021)

Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
por: Cheng, Jen-Yu, et al.
Publicado: (2020)

Corrigendum: Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis
por: Zhang, Fan, et al.
Publicado: (2016)

Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study
por: Mi, Yin, et al.
Publicado: (2020)

The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database
por: Li, Yongfeng, et al.
Publicado: (2019)

Increased risk of suicide attempt among patients receiving blood transfusion: A propensity matched analysis
por: Hu, Wei-Syun, et al.
Publicado: (2021)

Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis
por: Bowen, Megan E., et al.
Publicado: (2017)

Participation of the PI-3K/Akt-NF-κB signaling pathways in hypoxia-induced mitogenic factor-stimulated Flk-1 expression in endothelial cells
por: Tong, Qiangsong, et al.
Publicado: (2006)

Adjuvant radiotherapy for patients with pathologic node‐negative esophageal carcinoma: A population based propensity matching analysis
por: Gao, Hui‐Jiang, et al.
Publicado: (2019)

Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy
por: Li, Wen-Fei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lpl3dv4evcce88ptm1l490fk5t